Home
About us
News
Careers
Responsibility
Conditions
Healthline
Investors
Licensing
Contact Us
09 June 2004

CRESTOR® (rosuvastatin) Important changes to prescribing Information

AstraZeneca has sent a letter to Healthcare Professionals informing them of important changes to the CRESTOR prescribing information.

Please click here to view the letter

For any questions on CRESTOR, please call the Medical Information Department on 01582 836836.

> Tell a friend

> Global info
> Advanced search
>
UK media contacts
>
Journalists
>  Legal notice   >  Privacy policy >  © AstraZeneca 2007